These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30887112)

  • 21. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
    J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.
    Herman SE; Gordon AL; Hertlein E; Ramanunni A; Zhang X; Jaglowski S; Flynn J; Jones J; Blum KA; Buggy JJ; Hamdy A; Johnson AJ; Byrd JC
    Blood; 2011 Jun; 117(23):6287-96. PubMed ID: 21422473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway.
    Smith CIE; Burger JA
    Front Immunol; 2021; 12():689472. PubMed ID: 34177947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.
    Montresor A; Toffali L; Rigo A; Ferrarini I; Vinante F; Laudanna C
    Oncotarget; 2018 Oct; 9(80):35123-35140. PubMed ID: 30416684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-binding activity of NF-kappaB and phosphorylation of p65 are induced by N-acetylcysteine through phosphatidylinositol (PI) 3-kinase.
    Liu J; Yoshida Y; Yamashita U
    Mol Immunol; 2008 Sep; 45(15):3984-9. PubMed ID: 18657320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2.
    Anto RJ; Mukhopadhyay A; Shishodia S; Gairola CG; Aggarwal BB
    Carcinogenesis; 2002 Sep; 23(9):1511-8. PubMed ID: 12189195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.
    Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI
    Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
    Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Hirata Y
    J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.
    Nomura F; Kawai T; Nakanishi K; Akira S
    Genes Cells; 2000 Mar; 5(3):191-202. PubMed ID: 10759890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
    Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
    Front Immunol; 2019; 10():95. PubMed ID: 30761150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation.
    Bajpai UD; Zhang K; Teutsch M; Sen R; Wortis HH
    J Exp Med; 2000 May; 191(10):1735-44. PubMed ID: 10811866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IKK-IkappaB-NF-kappaB pathway in IgE-dependent mast cell activation.
    Peng Y; Power MR; Li B; Lin TJ
    J Leukoc Biol; 2005 Jun; 77(6):975-83. PubMed ID: 15784689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells.
    Bone H; Williams NA
    Int Immunol; 2001 Jun; 13(6):807-16. PubMed ID: 11369709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.